Learn More About Novartis Oncology at www.thewideprogram.com
   
WIDE Program: Worldwide Initiative to Develop Everolimus
Print This Page   Email This Page
 
Novartis Oncology
Search :
 

About Novartis Oncology

   » Home » About Novartis Oncology
 

About Novartis Oncology

At Novartis Oncology, our employees worldwide share a common mission: discover and develop innovative medicines to fight cancer. Headquartered in Florham Park, New Jersey, we are passionate about providing a broad range of new remedies and practical solutions that change the way patients live with cancer.


With more than 4,500 employees operating in over 50 countries, Novartis Oncology has a truly global reach. We have the advantage of extraordinarily talented and globally diverse employees who, through shared goals and different perspectives, are dedicated to improving and extending the lives of patients around the world.


We have a proven track record of providing new and improved cancer treatments and are continually discovering and developing new therapies that change lives. We are currently concentrating efforts on research platforms spanning discoveries in signal transduction inhibition, cytotoxic agents, antiangiogenesis, cell cyle/apoptosis, iron chelation, metastases and hormone therapy.


Learn more at Novartisoncology.com.

 
Disclaimer : These are investigational studies; there is no guarantee that everolimus will become commercially available for these indications
 
Disclaimer : This is an international web site for the The WIDE Program™ providing general information for healthcare professionals from all countries. The information on this site is not country-specific and may contain information that is different from where you practice. Please contact your local Novartis Medical Scientific Liaison for the latest information specific to your country.
Home | Renal Cell Carcinoma - RCC | Breast Cancer | Lymphoma - MCL & DLBCL | Tuberous Sclerosis Complex - TSC
Hepatocellular Carcinoma - HCC | Gastric Cancer | About Novartis | Tell a Colleague
Contact Us | Site Map | Terms of Use | Privacy Policy © 2010 Novartis AG